Form 4: Cytek Biosciences Director Michael Holder Reports Stock Transactions
SEC Form 4 Filing
Director Michael Holder reports the vesting of restricted stock units into Cytek Biosciences common stock.
Summary
- On August 19, 2024, Michael Holder, a director of Cytek Biosciences, Inc., had 1,454 restricted stock units (RSUs) vest and convert into common stock.
- Following the transaction, Holder directly owns 1,454 shares of Cytek Biosciences common stock.
- Holder also owns 24,724 derivative securities in the form of restricted stock units.
Sentiment
Score: 5
Explanation: This is a routine regulatory filing related to stock transactions by a company director, and does not inherently indicate positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of the US stock market and are required by the SEC to ensure transparency of trading by corporate insiders.
Stakeholder Impact
- The transaction has a minor impact on shareholders as it reflects insider activity and changes in ownership.
Key Dates
| Date | Description |
|---|---|
| 08/19/2024 | Date of transaction: vesting of restricted stock units and conversion to common stock. |
| 08/21/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.